Cargando…

Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations

[Image: see text] The residence time (RT), the time for which a drug remains bound to its biological target, is a critical parameter for drug design. The prediction of this key kinetic property has been proven to be challenging and computationally demanding in the framework of atomistic simulations....

Descripción completa

Detalles Bibliográficos
Autores principales: Galvani, Francesca, Pala, Daniele, Cuzzolin, Alberto, Scalvini, Laura, Lodola, Alessio, Mor, Marco, Rizzi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170513/
https://www.ncbi.nlm.nih.gov/pubmed/37053454
http://dx.doi.org/10.1021/acs.jcim.3c00042
_version_ 1785039243700076544
author Galvani, Francesca
Pala, Daniele
Cuzzolin, Alberto
Scalvini, Laura
Lodola, Alessio
Mor, Marco
Rizzi, Andrea
author_facet Galvani, Francesca
Pala, Daniele
Cuzzolin, Alberto
Scalvini, Laura
Lodola, Alessio
Mor, Marco
Rizzi, Andrea
author_sort Galvani, Francesca
collection PubMed
description [Image: see text] The residence time (RT), the time for which a drug remains bound to its biological target, is a critical parameter for drug design. The prediction of this key kinetic property has been proven to be challenging and computationally demanding in the framework of atomistic simulations. In the present work, we setup and applied two distinct metadynamics protocols to estimate the RTs of muscarinic M3 receptor antagonists. In the first method, derived from the conformational flooding approach, the kinetics of unbinding is retrieved from a physics-based parameter known as the acceleration factor α (i.e., the running average over time of the potential deposited in the bound state). Such an approach is expected to recover the absolute RT value for a compound of interest. In the second method, known as the t(META-D) approach, a qualitative estimation of the RT is given by the time of simulation required to drive the ligand from the binding site to the solvent bulk. This approach has been developed to reproduce the change of experimental RTs for compounds targeting the same target. Our analysis shows that both computational protocols are able to rank compounds in agreement with their experimental RTs. Quantitative structure–kinetics relationship (SKR) models can be identified and employed to predict the impact of a chemical modification on the experimental RT once a calibration study has been performed.
format Online
Article
Text
id pubmed-10170513
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-101705132023-05-11 Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations Galvani, Francesca Pala, Daniele Cuzzolin, Alberto Scalvini, Laura Lodola, Alessio Mor, Marco Rizzi, Andrea J Chem Inf Model [Image: see text] The residence time (RT), the time for which a drug remains bound to its biological target, is a critical parameter for drug design. The prediction of this key kinetic property has been proven to be challenging and computationally demanding in the framework of atomistic simulations. In the present work, we setup and applied two distinct metadynamics protocols to estimate the RTs of muscarinic M3 receptor antagonists. In the first method, derived from the conformational flooding approach, the kinetics of unbinding is retrieved from a physics-based parameter known as the acceleration factor α (i.e., the running average over time of the potential deposited in the bound state). Such an approach is expected to recover the absolute RT value for a compound of interest. In the second method, known as the t(META-D) approach, a qualitative estimation of the RT is given by the time of simulation required to drive the ligand from the binding site to the solvent bulk. This approach has been developed to reproduce the change of experimental RTs for compounds targeting the same target. Our analysis shows that both computational protocols are able to rank compounds in agreement with their experimental RTs. Quantitative structure–kinetics relationship (SKR) models can be identified and employed to predict the impact of a chemical modification on the experimental RT once a calibration study has been performed. American Chemical Society 2023-04-13 /pmc/articles/PMC10170513/ /pubmed/37053454 http://dx.doi.org/10.1021/acs.jcim.3c00042 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Galvani, Francesca
Pala, Daniele
Cuzzolin, Alberto
Scalvini, Laura
Lodola, Alessio
Mor, Marco
Rizzi, Andrea
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
title Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
title_full Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
title_fullStr Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
title_full_unstemmed Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
title_short Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
title_sort unbinding kinetics of muscarinic m3 receptor antagonists explained by metadynamics simulations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170513/
https://www.ncbi.nlm.nih.gov/pubmed/37053454
http://dx.doi.org/10.1021/acs.jcim.3c00042
work_keys_str_mv AT galvanifrancesca unbindingkineticsofmuscarinicm3receptorantagonistsexplainedbymetadynamicssimulations
AT paladaniele unbindingkineticsofmuscarinicm3receptorantagonistsexplainedbymetadynamicssimulations
AT cuzzolinalberto unbindingkineticsofmuscarinicm3receptorantagonistsexplainedbymetadynamicssimulations
AT scalvinilaura unbindingkineticsofmuscarinicm3receptorantagonistsexplainedbymetadynamicssimulations
AT lodolaalessio unbindingkineticsofmuscarinicm3receptorantagonistsexplainedbymetadynamicssimulations
AT mormarco unbindingkineticsofmuscarinicm3receptorantagonistsexplainedbymetadynamicssimulations
AT rizziandrea unbindingkineticsofmuscarinicm3receptorantagonistsexplainedbymetadynamicssimulations